Pyxis Oncology
PYXS
PYXS
78 hedge funds and large institutions have $34.7M invested in Pyxis Oncology in 2025 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5.15% more ownership
Funds ownership: 43.26% → 48.41% (+5.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
42% less capital invested
Capital invested by funds: $59.7M → $34.7M (-$25.1M)
Holders
78
Holding in Top 10
1
Calls
$584K
Puts
$86K
Top Buyers
| 1 | +$4.13M | |
| 2 | +$2.18M | |
| 3 | +$1.7M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.37M |
| 5 |
6CM
683 Capital Management
New York
|
+$1.29M |
Top Sellers
| 1 | -$5.55M | |
| 2 | -$2.62M | |
| 3 | -$1.53M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$929K |
| 5 |
SC
Schulhoff & Co
Cincinnati,
Ohio
|
-$611K |
